Source: PR NEWSWIRE

Press Release: CORD:USE : CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases

ORLANDO, Fla., Sept. 30, 2014 /PRNewswire/ -- CORD:USE Cord Blood Bank - www.corduse.com - is pleased to announce that it has entered into an Equity and Exclusive Services Agreement with Tianhe Stem Cell Biotechnologies, Inc. (Tianhe) which has licensed a series of...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Edward Guindi's photo - President & CEO of CORD:USE

President & CEO

Edward Guindi

CEO Approval Rating

78/100

Read more